Entheon Biomedical Corp

ENBI
OTCQB: ENTBF
Request Investor Info

Entheon Biomedical is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective N, N-dimethyltryptamine-based psychedelic therapeutic products (“DMT Products”) for the purposes of treating addiction and substance use disorders.

Projects
Stories
Presentation
Contact
Management
Financials
Entheon Biomedical Corp Stock Price Today
Entheon Biomedical Corp Fundamental Data by TradingView

Company Feed

Entheon Biomedical
December 16, 2021

Investor Alert: Entheon Biomedical - Treating Addiction

Entheon Biomedical is a biotechnology research and development company committed to developing and commercializing a portfolio of safe and effective N …

This is some text inside of a div block.
Entheon Biomedical
August 20, 2021

Entheon Biomedical: Looking to Remedy the Root Causes of Addiction

With an expert team of scientists and world-class advisors, Entheon Biomedical is looking to remedy the root causes of addiction. Additionally, The co …

This is some text inside of a div block.
Entheon Biomedical psychedelics mental health BTV psychedelic therapy
July 21, 2021

Entheon Biomedical: Psychedelic Medicines to Treat Addiction

Entheon Biomedical is pioneering a leading-edge addiction recovery solution that harnesses the therapeutic potential of patient-centric psychedelic me …

This is some text inside of a div block.
Entheon Biomedical psychedelics
July 12, 2021

Entheon Biomedical: Innovative Addiction Treatment

Entheon is a biotechnology research and development company. They're committed to developing and commercializing a portfolio of safe and effective N,N …

This is some text inside of a div block.
Subscribe and receive the investor Info